Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diabetes vaccine based on (M)T-DC (Target-dendritic cell) technology

A diabetes vaccine and T-DC technology, applied in the field of vaccines, can solve problems such as cardiovascular and cerebrovascular damage, decline in blood supply system function, and decline in vascular cell function, and achieve the effect of strengthening, preventing recurrence or reinfection, and restoring pancreatic function.

Inactive Publication Date: 2018-07-06
西安华洲生物科技有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long-term low-virulence infection will cause the immune system to gradually adapt to this infection. In the case of low immunity, the corresponding immune response cannot be caused against it, resulting in immune tolerance. The body cannot recognize the relevant pathogenic microorganisms, which will lead to pathogenic microorganisms. Long-term persistent infection, causing long-term damage to the body
[0004] This type of infection will cause serious pathological damage to the cardiovascular and cerebrovascular, and the continuous damage of vascular endothelial cells will cause diseases of the vascular system; the destruction of the vascular endothelium will form microthrombi, and the formation of microthrombi will block capillaries, resulting in the slow function of vascular cells. Regression, the progressive damage of blood vessels slowly accumulates, from quantitative deformation to qualitative change, once a breakthrough occurs, the damage to organ function is irreversible; it will lead to a decline in the function of the blood supply system, and damage to blood vessel function will lead to the occurrence of diseases such as diabetes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diabetes vaccine based on (M)T-DC (Target-dendritic cell) technology
  • Diabetes vaccine based on (M)T-DC (Target-dendritic cell) technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] The present invention will be described in detail below in combination with specific embodiments.

[0018] Targeted dendritic cell therapy (Target-Dendritic Cell, T-DC) is to collect autologous peripheral blood mononuclear cells, and add other cytokines in the laboratory to obtain transformed dendritic cells (dendritic cells) with strong antigen-presenting function. , DC). The day before the reinfusion, a specially synthesized single-epitope polyantigen peptide is added, and the DC recognizes and captures the single-epitope polyantigen peptide to obtain mature dendritic cells that are sensitized to the patient's infectious agent virus. Migration and immune activity, go deep into the deep part of the lesion and the surrounding diseased tissue, induce the body to produce a large number of cytotoxic T lymphocytes that have a killing effect on specific antigens, thereby specifically clearing the free virus and intracellular virus in the deep layer of infection and around it...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to diabetes vaccine based on a (M)T-DC (Target-dendritic cell) technology. The vaccine is a dendritic cell preparation obtained by using specific single-epitope multiple antigenpeptides for in-vitro sensitization of dendritic cell and is venous re-transfusion type diabetes vaccine. Removal of a vascular endothelial infection factor is interfered by the (M)T-DC technology, the vaccine can penetrate into the local lesion in a targeted way, corresponding treatment courses of mesenchymal stem cell treatment with multidirectional differentiation potential is also adopted, soas to repair blood vessel endothelium, cicatrix is dissolved, a pancreatic intra-tissue repairing is realized, a pancreatic immune system is repaired and the insulin beta cell function is recovered, so that the treatment aim of enabling insulin secretion to be normal is fulfilled.

Description

technical field [0001] The invention relates to a vaccine, in particular to a diabetes vaccine based on (M)T-DC technology. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by hyperglycemia due to defects in insulin secretion or insulin β-cell action. Sustained high blood sugar and long-term metabolic disorders can lead to damage, dysfunction and failure of tissues and organs throughout the body, especially the eyes, kidneys, cardiovascular and nervous systems. Severe cases can cause acute complications such as dehydration, electrolyte disturbance and acid-base imbalance, ketoacidosis and hyperosmolar coma. Drugs and diet are used in treatment, but it is difficult to achieve the desired effect. [0003] According to research, cytotoxin-associated protein (CagA), vacuolar toxin-associated protein (VacA), urease (Ure), cytomegalovirus (CMV), human papillomavirus (HPV-16), human papillomavirus (HPV- 18), herpes simplex virus-II (HSV-II), C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/00A61P3/10
CPCA61K39/0005A61K2039/572
Inventor 闫小君闫龙
Owner 西安华洲生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products